
The hormone replacement therapy (HRT) taskforce has been wound up following an “improvement” in supply of the drugs used to alleviate menopause symptoms, the Department of Health and Social Care has said.
The head of the vaccine taskforce was reassigned to help with the HRT shortage earlier this year.